| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.2 | 8e-06 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.16 | 0.0004 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.097 | 0.06 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.085 | 0.06 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.068 | 0.1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.056 | 0.2 |